These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19808684)

  • 1. A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity.
    Timmerman P; Barderas R; Desmet J; Altschuh D; Shochat S; Hollestelle MJ; Höppener JW; Monasterio A; Casal JI; Meloen RH
    J Biol Chem; 2009 Dec; 284(49):34126-34. PubMed ID: 19808684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of CDR-derived peptides is mechanistically different from that of high-affinity parental antibodies.
    Timmerman P; Shochat SG; Desmet J; Barderas R; Casal JI; Meloen RH; Altschuh D
    J Mol Recognit; 2010; 23(6):559-68. PubMed ID: 21038356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downsizing antibodies: Towards complementarity-determining region (CDR)-based peptide mimetics.
    Van Holsbeeck K; Martins JC; Ballet S
    Bioorg Chem; 2022 Feb; 119():105563. PubMed ID: 34942468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries.
    Azevedo Reis Teixeira A; Erasmus MF; D'Angelo S; Naranjo L; Ferrara F; Leal-Lopes C; Durrant O; Galmiche C; Morelli A; Scott-Tucker A; Bradbury ARM
    MAbs; 2021; 13(1):1980942. PubMed ID: 34850665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.
    Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z
    Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity maturation of antibodies assisted by in silico modeling.
    Barderas R; Desmet J; Timmerman P; Meloen R; Casal JI
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9029-34. PubMed ID: 18574150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance.
    Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK
    Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
    Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
    J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatitis C virus NS3 protease by peptides derived from complementarity-determining regions (CDRs) of the monoclonal antibody 8D4: tolerance of a CDR peptide to conformational changes of a target.
    Tsumoto K; Misawa S; Ohba Y; Ueno T; Hayashi H; Kasai N; Watanabe H; Asano R; Kumagai I
    FEBS Lett; 2002 Aug; 525(1-3):77-82. PubMed ID: 12163165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
    Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
    Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.
    Montgomery DL; Wang YJ; Hrin R; Luftig M; Su B; Miller MD; Wang F; Haytko P; Huang L; Vitelli S; Condra J; Liu X; Hampton R; Carfi A; Pessi A; Bianchi E; Joyce J; Lloyd C; Geleziunas R; Bramhill D; King VM; Finnefrock AC; Strohl W; An Z
    MAbs; 2009; 1(5):462-74. PubMed ID: 20065653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial mutagenesis with alternative CDR-L1 and -H2 loop lengths contributes to affinity maturation of antibodies.
    Brockmann EC; Pyykkö M; Hannula H; Khan K; Lamminmäki U; Huovinen T
    N Biotechnol; 2021 Jan; 60():173-182. PubMed ID: 33039698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Array-Based Rational Design of Short Peptide Probe-Derived from an Anti-TNT Monoclonal Antibody.
    Okochi M; Muto M; Yanai K; Tanaka M; Onodera T; Wang J; Ueda H; Toko K
    ACS Comb Sci; 2017 Oct; 19(10):625-632. PubMed ID: 28845964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for antigen recognition by methylated lysine-specific antibodies.
    Ishii M; Nakakido M; Caaveiro JMM; Kuroda D; Okumura CJ; Maruyama T; Entzminger K; Tsumoto K
    J Biol Chem; 2021; 296():100176. PubMed ID: 33303630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human synthetic combinatorial library of arrayable single-chain antibodies based on shuffling in vivo formed CDRs into general framework regions.
    Azriel-Rosenfeld R; Valensi M; Benhar I
    J Mol Biol; 2004 Jan; 335(1):177-92. PubMed ID: 14659749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro affinity maturation of HuCAL antibodies: complementarity determining region exchange and RapMAT technology.
    Prassler J; Steidl S; Urlinger S
    Immunotherapy; 2009 Jul; 1(4):571-83. PubMed ID: 20635988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.